title: Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment.
authors.affiliation: Paracelsus Medical University, Christian-Doppler-Klinik, University Hospital of Neurology, Salzburg, Austria. p.wipfler@salk.at
authors.forename: P
authors.initials: P
authors.lastname: Wipfler
authors.forename: K
authors.initials: K
authors.lastname: Oppermann
authors.forename: G
authors.initials: G
authors.lastname: Pilz
authors.forename: S
authors.initials: S
authors.lastname: Afazel
authors.forename: E
authors.initials: E
authors.lastname: Haschke-Becher
authors.forename: A
authors.initials: A
authors.lastname: Harrer
authors.forename: M
authors.initials: M
authors.lastname: Huemer
authors.forename: A
authors.initials: A
authors.lastname: Kunz
authors.forename: S
authors.initials: S
authors.lastname: Golaszewski
authors.forename: W
authors.initials: W
authors.lastname: Staffen
authors.forename: G
authors.initials: G
authors.lastname: Ladurner
authors.forename: J
authors.initials: J
authors.lastname: Kraus